Get the Stockscreener App
72.86
2.14%
1.53
Pre-market:
72.72
-0.14
-0.19%
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $72.86, with a volume of 3.84M.
It is up +2.14% in the last 24 hours and down -6.27% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$71.33
Open:
$71.98
24h Volume:
3.84M
Relative Volume:
0.62
Market Cap:
$30.11B
Revenue:
$9.51B
Net Income/Loss:
$2.64B
P/E Ratio:
12.07
EPS:
6.0361
Net Cash Flow:
$2.14B
1W Performance:
-0.78%
1M Performance:
-6.27%
6M Performance:
-37.01%
1Y Performance:
-49.63%
1-Day Range:
$71.24
$73.46
1-Week Range:
$70.26
$73.90
52-Week Range:
$70.26
$148.79
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
72.86 | 30.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
18.95 | 58.31B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.52 | 43.22B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.25 | 40.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
497.59 | 21.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Jan-22-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Michael Burry Sells FLUT To Pile Into LULU Under $100 — Plus A New Bet On ZTS - TradingView
Why Are Zoetis (NYSE:ZTS) Diagnostics in S&P 500 Focus? - Kalkine Media
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? - Yahoo Finance
Zoetis Shares Slide Following Earnings RevisionEarnings Deceleration Risk - vinanet.vn
Zoetis Stock (ZTS) Opinions on Michael Burry Portfolio Update - Moomoo
Zoetis Taps Former GE HealthCare CFO Jay Saccaro as CFO and COO - The Healthcare Technology Report.
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Paws and profits: Zoetis appoints global diagnostics president, NVA names chief medical officer, and more updates - DVM360
Zoetis (ZTS) Shares Drop After Earnings Revision - Yahoo Finance
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
Zoetis Inc. (ZTS) Investor Outlook: Unlocking a 26.63% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Is Zoetis Stock Underperforming the S&P 500? - Yahoo Finance
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - BioSpace
Zoetis (NYSE:ZTS) Offers Value and Quality in One Attractive Package - ChartMill
Zoetis Inc. (ZTS) - DirectorsTalk Interviews
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Is It Too Late to Buy Zoetis Inc (ZTS) After 3.1% Rally? GF Value Says Undervalued - GuruFocus
A Look at Zoetis Inc (ZTS) After 3.2% Decline -- GF Value $180.6 - GuruFocus
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Bull Case For Zoetis (ZTS) Could Change Following FDA Emergency Use Authorization For Simparica Trio - simplywall.st
Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business? - Yahoo Finance
MS Global Franchise Portfolio's Bold Q2 2026 Move: Exits Zoetis Inc, a -2.6% Portfolio Impact - Yahoo Finance
Zoetis Inc. $ZTS Shares Acquired by Wealthfront Advisers LLC - MarketBeat
Zoetis Updates Prescribing Information for FACTREL Cattle Injection - geneonline.com
ZTS Maintained by Stifel -- Price Target Lowered to $80 - GuruFocus
Stifel Nicolaus Has Lowered Expectations for Zoetis (NYSE:ZTS) Stock Price - MarketBeat
Stifel cuts Zoetis stock price target on key franchise weakness - Investing.com
Stifel cuts Zoetis stock price target on key franchise weakness By Investing.com - Investing.com India
Meeder Asset Management Inc. Sells 42,497 Shares of Zoetis Inc. $ZTS - MarketBeat
Flossbach Von Storch SE Buys Shares of 4,210,978 Zoetis Inc. $ZTS - MarketBeat
Tranche Update on Zoetis Inc.'s Equity Buyback Plan announced on August 1, 2024. - marketscreener.com
Zoetis Inc (ZTS) Shares Surge 3.7% -- What GF Score of 64 Tells Investors - GuruFocus
Zoetis Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Zoetis appoints Jay Saccaro as CFO and COO - WATTPoultry.com
Zoetis (ZTS) Stock Still Looks Cheap After a 62% Slide - Yahoo Finance
Is Zoetis’ Lowered 2026 Outlook and Simparica Trio EUA Altering The Investment Case For Zoetis (ZTS)? - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Has $76.91 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Main Street Financial Solutions LLC Makes New Investment in Zoetis Inc. $ZTS - MarketBeat
How a new AI value framework and stakeholder focus keep Zoetis ahead of the pack - cio.com
BlackRock Inc. Grows Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc (MIL:1ZTS) Stock Price, Trades & News - GuruFocus
How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA - simplywall.st
iShares Disciplined Volatility Equity Active ETF's Zoetis Inc(ZTS) Holding History - GuruFocus
Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy? - Yahoo Finance
Zoetis Inc. $ZTS Shares Bought by Texas Capital Bank Wealth Management Services Inc - MarketBeat
Deutsche Bank AG Purchases 319,709 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis’ pain therapy Portela receives VMD approval - Vet Times
Zoetis: A Solid Long-Term Buy After Harsh Drawdown (NYSE:ZTS) - Seeking Alpha
18,470 Shares in Zoetis Inc. $ZTS Purchased by GSA Capital Partners LLP - MarketBeat
Flputnam Investment Management Co. Raises Stock Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):